Risk of Radiation -Associated Secondary Malignancies among Patients with Breast Cancer Harboring TP53 Germline Variants

被引：0
|
作者：
Cederquist, G. [1 ]
Boe, L. [2 ]
Walsh, M. F. [3 ]
Stadler, Z. [4 ]
Xu, A. J. [5 ]
Mueller, B. A. [5 ]
O'Brien, D. A. Roth [5 ]
Bernstein, M. B. [5 ]
Cuaron, J. [5 ]
Bakhoum, S. F. [3 ]
Powell, S. N. [5 ]
Khan, A. J. [5 ]
Robson, M. E. [4 ]
Maxwell, K. [6 ]
Taunk, N. K. [7 ]
Braunstein, L. Z. [5 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Radiat Oncol, New York, NY USA
[2] Mem Sloan Kettering, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY USA
[6] Univ Penn, Philadelphia, PA USA
[7] Univ Penn, Hosp, Philadelphia, PA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
181
引用
收藏
页码：S45 / S46
页数：2
相关论文
共 50 条
  • [21] Phenotype analysis of families with TP53 germline variants at the Center for Familial Breast and Ovarian Cancer, Cologne
    Kast, K.
    Rhiem, K.
    Larsen, M.
    Wappenschmidt, B.
    Schmutzler, R.
    CANCER MEDICINE, 2024, 13 (03):
  • [22] Germline TP53 mutational spectrum in French Canadians with breast cancer
    Arcand, Suzanna L.
    Akbari, Mohammed R.
    Mes-Masson, Anne-Marie
    Provencher, Diane
    Foulkes, William D.
    Narod, Steven A.
    Tonin, Patricia N.
    BMC Medical Genetics, 2015, 16
  • [23] TP53 germline mutation testing in early onset breast cancer
    Conte, B.
    Varesco, L.
    Iacono, G.
    Poggio, F.
    Blondeaux, E.
    Levaggi, A.
    D'Alonzo, A.
    Bighin, C.
    Giraudi, S.
    Vaglica, M.
    Pronzato, P.
    Del Mastro, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] Pathogenic germline variants in BRCA1 and TP53 increase lung cancer risk in Chinese
    Wei, Bing
    Zhao, Jiadong
    Li, Jun
    Feng, Junnan
    Sun, Manman
    Wang, Zhizhong
    Shi, Chao
    Yang, Ke
    Qin, Yue
    Zhang, Jing
    Ma, Jie
    Dong, Hui
    CANCER MEDICINE, 2023, 12 (23): : 21219 - 21228
  • [25] Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
    A Langerød
    TI Andersen
    I Bukholm
    A-L Børresen Dale
    Breast Cancer Research, 2 (Suppl 1)
  • [26] Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations
    Alyami, Hassan
    Yoo, Tae Kyung
    Cheun, Jong Ho
    Lee, Han Byoel
    Jung, Sung Mi
    Ryu, Jai Min
    Bae, Soong June
    Jeong, Joon
    Yoon, Chang Ik
    Ahn, Juneyoung
    Paik, Pill Sun
    Cho, Min Kyung
    Park, Woo Chan
    JOURNAL OF BREAST CANCER, 2021, 24 (02) : 175 - 182
  • [27] Risk of therapy-related subsequent cancers in individuals with germline TP53 variants
    Villani, Anita
    Khincha, Payal
    Hatton, Jessica
    Schonfeld, Sara
    Goudie, Catherine
    Oba, Leatrisse
    Pithadia, Kishan
    Sanger, Birte
    Kratz, Christian
    Le, Anh N.
    Orr, Caitlin
    Maxwell, Kara N.
    Naumer, Anne
    Vagher, Jennie
    Kohlmann, Wendy
    Schi, Joshua
    dos Santos, Elizabeth Santana
    Michaeli, Orli
    Carson, Jacob J.
    Tsang, Derek S.
    Kim, Raymond
    Maciaszek, Jamie L.
    Nichols, Kim E.
    Goodman, Victoria E.
    MacFarland, Suzanne P.
    Reichman, Lara
    Achatz, Maria Isabel
    Savage, Sharon
    Malkin, David
    Morton, Lindsay M.
    CANCER RESEARCH, 2024, 84 (17)
  • [28] Impact of germline TP53 mutations and polymorphisms in women with premenopausal breast cancer
    Samuel, Nardin
    Novokmet, Ana
    Hudson, Thomas J.
    Malkin, David
    CANCER RESEARCH, 2014, 74 (23)
  • [29] Early onset HER2-positive breast cancer is associated with germline TP53 mutations
    Melhem-Bertrandt, Amal
    Bojadzieva, Jasmina
    Ready, Kaylene J.
    Obeid, Elias
    Liu, Diane D.
    Gutierrez-Barrera, Angelica M.
    Litton, Jennifer K.
    Olopade, Olufunmilayo I.
    Hortobagyi, Gabriel N.
    Strong, Louise C.
    Arun, Banu K.
    CANCER, 2012, 118 (04) : 908 - 913
  • [30] A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA
    Gemignani, F
    Moreno, V
    Landi, S
    Moullan, N
    Chabrier, A
    Gutiérrez-Enríquez, S
    Hall, J
    Guino, E
    Peinado, MA
    Capella, G
    Canzian, F
    ONCOGENE, 2004, 23 (10) : 1954 - 1956
12345